Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury.

Byung Hee Han, Daigen Xu, Junjeong Choi, Yongxin Han, Steven Xanthoudakis, Sophie Roy, John Tam, John Vaillancourt, John Colucci, Robert Siman, Andre Giroux, George S. Robertson, Robert Zamboni, Donald W. Nicholson, David M. Holtzman

Research output: Contribution to journalArticle

152 Citations (Scopus)

Abstract

Hypoxia-ischemia (H-I) in the developing brain results in brain injury with prominent features of both apoptosis and necrosis. A peptide-based pan-caspase inhibitor is neuroprotective against neonatal H-I brain injury, suggesting a central role of caspases in brain injury. Because previously studied peptide-based caspase inhibitors are not potent and are only partially selective, the exact contribution of specific caspases and other proteases to injury after H-I is not clear. In this study, we explored the neuroprotective effects of a small, reversible caspase-3 inhibitor M826. M826 selectively and potently inhibited both caspase-3 enzymatic activity and apoptosis in cultured cells in vitro. In a rat model of neonatal H-I, M826 blocked caspase-3 activation and cleavage of its substrates, which begins 6 h and peaks 24 h after H-I. Although M826 significantly reduced DNA fragmentation and brain tissue loss, it did not prevent calpain activation in the cortex. This activation, which is associated with excitotoxic/necrotic cell injury, occurred within 30 min to 2 h after H-I even in the presence of M826. Similar to calpain activation, we found evidence of caspase-2 processing within 30 min to 2 h after H-I that was not affected by M826. Caspase-2 processing appeared to be secondary to calpain-mediated cleavage and was not associated with caspase-2 activation. These data suggest that caspase-3 specifically contributes to delayed cell death and brain injury after neonatal H-I and that calpain activation is associated with and likely a marker for the early component of excitotoxic/necrotic brain injury previously demonstrated in this model.

Original languageEnglish
Pages (from-to)30128-30136
Number of pages9
JournalThe Journal of biological chemistry
Volume277
Issue number33
DOIs
Publication statusPublished - 2002 Jan 1

Fingerprint

Caspase Inhibitors
Cell death
Caspase 3
Brain Injuries
Brain
Cell Death
Ischemia
Calpain
Chemical activation
Caspase 2
Caspases
Apoptosis
Peptides
Wounds and Injuries
Neuroprotective Agents
DNA Fragmentation
Processing
Hypoxia
Rats
Cultured Cells

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Han, Byung Hee ; Xu, Daigen ; Choi, Junjeong ; Han, Yongxin ; Xanthoudakis, Steven ; Roy, Sophie ; Tam, John ; Vaillancourt, John ; Colucci, John ; Siman, Robert ; Giroux, Andre ; Robertson, George S. ; Zamboni, Robert ; Nicholson, Donald W. ; Holtzman, David M. / Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. In: The Journal of biological chemistry. 2002 ; Vol. 277, No. 33. pp. 30128-30136.
@article{92ac6d3bae1345049b5f30469a7171bc,
title = "Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury.",
abstract = "Hypoxia-ischemia (H-I) in the developing brain results in brain injury with prominent features of both apoptosis and necrosis. A peptide-based pan-caspase inhibitor is neuroprotective against neonatal H-I brain injury, suggesting a central role of caspases in brain injury. Because previously studied peptide-based caspase inhibitors are not potent and are only partially selective, the exact contribution of specific caspases and other proteases to injury after H-I is not clear. In this study, we explored the neuroprotective effects of a small, reversible caspase-3 inhibitor M826. M826 selectively and potently inhibited both caspase-3 enzymatic activity and apoptosis in cultured cells in vitro. In a rat model of neonatal H-I, M826 blocked caspase-3 activation and cleavage of its substrates, which begins 6 h and peaks 24 h after H-I. Although M826 significantly reduced DNA fragmentation and brain tissue loss, it did not prevent calpain activation in the cortex. This activation, which is associated with excitotoxic/necrotic cell injury, occurred within 30 min to 2 h after H-I even in the presence of M826. Similar to calpain activation, we found evidence of caspase-2 processing within 30 min to 2 h after H-I that was not affected by M826. Caspase-2 processing appeared to be secondary to calpain-mediated cleavage and was not associated with caspase-2 activation. These data suggest that caspase-3 specifically contributes to delayed cell death and brain injury after neonatal H-I and that calpain activation is associated with and likely a marker for the early component of excitotoxic/necrotic brain injury previously demonstrated in this model.",
author = "Han, {Byung Hee} and Daigen Xu and Junjeong Choi and Yongxin Han and Steven Xanthoudakis and Sophie Roy and John Tam and John Vaillancourt and John Colucci and Robert Siman and Andre Giroux and Robertson, {George S.} and Robert Zamboni and Nicholson, {Donald W.} and Holtzman, {David M.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1074/jbc.M202931200",
language = "English",
volume = "277",
pages = "30128--30136",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "33",

}

Han, BH, Xu, D, Choi, J, Han, Y, Xanthoudakis, S, Roy, S, Tam, J, Vaillancourt, J, Colucci, J, Siman, R, Giroux, A, Robertson, GS, Zamboni, R, Nicholson, DW & Holtzman, DM 2002, 'Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury.', The Journal of biological chemistry, vol. 277, no. 33, pp. 30128-30136. https://doi.org/10.1074/jbc.M202931200

Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. / Han, Byung Hee; Xu, Daigen; Choi, Junjeong; Han, Yongxin; Xanthoudakis, Steven; Roy, Sophie; Tam, John; Vaillancourt, John; Colucci, John; Siman, Robert; Giroux, Andre; Robertson, George S.; Zamboni, Robert; Nicholson, Donald W.; Holtzman, David M.

In: The Journal of biological chemistry, Vol. 277, No. 33, 01.01.2002, p. 30128-30136.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury.

AU - Han, Byung Hee

AU - Xu, Daigen

AU - Choi, Junjeong

AU - Han, Yongxin

AU - Xanthoudakis, Steven

AU - Roy, Sophie

AU - Tam, John

AU - Vaillancourt, John

AU - Colucci, John

AU - Siman, Robert

AU - Giroux, Andre

AU - Robertson, George S.

AU - Zamboni, Robert

AU - Nicholson, Donald W.

AU - Holtzman, David M.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Hypoxia-ischemia (H-I) in the developing brain results in brain injury with prominent features of both apoptosis and necrosis. A peptide-based pan-caspase inhibitor is neuroprotective against neonatal H-I brain injury, suggesting a central role of caspases in brain injury. Because previously studied peptide-based caspase inhibitors are not potent and are only partially selective, the exact contribution of specific caspases and other proteases to injury after H-I is not clear. In this study, we explored the neuroprotective effects of a small, reversible caspase-3 inhibitor M826. M826 selectively and potently inhibited both caspase-3 enzymatic activity and apoptosis in cultured cells in vitro. In a rat model of neonatal H-I, M826 blocked caspase-3 activation and cleavage of its substrates, which begins 6 h and peaks 24 h after H-I. Although M826 significantly reduced DNA fragmentation and brain tissue loss, it did not prevent calpain activation in the cortex. This activation, which is associated with excitotoxic/necrotic cell injury, occurred within 30 min to 2 h after H-I even in the presence of M826. Similar to calpain activation, we found evidence of caspase-2 processing within 30 min to 2 h after H-I that was not affected by M826. Caspase-2 processing appeared to be secondary to calpain-mediated cleavage and was not associated with caspase-2 activation. These data suggest that caspase-3 specifically contributes to delayed cell death and brain injury after neonatal H-I and that calpain activation is associated with and likely a marker for the early component of excitotoxic/necrotic brain injury previously demonstrated in this model.

AB - Hypoxia-ischemia (H-I) in the developing brain results in brain injury with prominent features of both apoptosis and necrosis. A peptide-based pan-caspase inhibitor is neuroprotective against neonatal H-I brain injury, suggesting a central role of caspases in brain injury. Because previously studied peptide-based caspase inhibitors are not potent and are only partially selective, the exact contribution of specific caspases and other proteases to injury after H-I is not clear. In this study, we explored the neuroprotective effects of a small, reversible caspase-3 inhibitor M826. M826 selectively and potently inhibited both caspase-3 enzymatic activity and apoptosis in cultured cells in vitro. In a rat model of neonatal H-I, M826 blocked caspase-3 activation and cleavage of its substrates, which begins 6 h and peaks 24 h after H-I. Although M826 significantly reduced DNA fragmentation and brain tissue loss, it did not prevent calpain activation in the cortex. This activation, which is associated with excitotoxic/necrotic cell injury, occurred within 30 min to 2 h after H-I even in the presence of M826. Similar to calpain activation, we found evidence of caspase-2 processing within 30 min to 2 h after H-I that was not affected by M826. Caspase-2 processing appeared to be secondary to calpain-mediated cleavage and was not associated with caspase-2 activation. These data suggest that caspase-3 specifically contributes to delayed cell death and brain injury after neonatal H-I and that calpain activation is associated with and likely a marker for the early component of excitotoxic/necrotic brain injury previously demonstrated in this model.

UR - http://www.scopus.com/inward/record.url?scp=0242663945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242663945&partnerID=8YFLogxK

U2 - 10.1074/jbc.M202931200

DO - 10.1074/jbc.M202931200

M3 - Article

VL - 277

SP - 30128

EP - 30136

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 33

ER -